MDB Capital Holdings LLC $(MDBH)$ provided an operational update for the third quarter ended September 30, 2025. The company announced it anticipates closing two offerings shortly: a $16.8 million private placement for Paulex Bio, a biopharmaceutical company focused on novel therapeutics for diabetes, and a $20 million IPO for Buda Juice, which specializes in UltraFresh™ cold-crafted juices, expected in December 2025. MDB Capital Holdings also reported expanded relationships with Registered Investment Advisors (RIAs) to reach new investors seeking alternative investment strategies, and welcomed TCA Venture Group and Keiretsu Forum MST angel group investors into its latest offerings. The company continues to improve the efficiency of its public venture platform and has expanded its pipeline of early-stage, disruptive companies.